PHVS: Pharvaris N.V. O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati
Pharvaris N.V. (PHVS) ishlab chiqarish va sinovlarni tashqi hamkorlarga topshirish orqali kapital xarajatlarini minimallashtiradi. AQSh va Yevropadagi global ishtirok bozorga kirishni osonlashtiradi, bradikinin antagonistlariga e'tibor qaratish esa shishlarni davolashda inqilobiy yutuqlarni va'da qiladi. GURU.Markets grafigidagi PEG koeffitsiyenti tarixi o'zgaruvchan kutishlarni aks ettiradi, bunda 0.00 belgisi biznesning qiymatini baholash uchun asosiy ko'rsatkich bo'lib xizmat qiladi.
Pharvaris N.V. (PHVS) kompaniyasi koʻrsatkichlari kesimi va tahlili
- aksiya narxi va baholash bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- kompaniyaning balans qiymati tafsilotlari:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Umumiy qarzning kapitalga nisbati Pharvaris N.V.|PHVS - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati ko'rsatkichi pharvaris.com|PHVS - Kompaniyaning jamlangan qarzlari|Balans qiymatiga qarzlar Pharvaris Corp|PHVS - Kompaniyaning uzoq muddatli qarzi|Qisqa muddatli majburiyatlar Pharvaris|Oraliq qoplash koeffitsiyenti pharvaris.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
PHVS - Sof foyda|Prognoz qilingan kelajakdagi foyda Pharvaris N.V.|PHVS - Narxning foydaga nisbati|Kelajakdagi narx-foyda multiplikatori Pharvaris Pharma|PHVS - Narx-foyda va o‘sish multiplikatori|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati Pharvaris Corp|PHVS - EBITDA operatsion foydasi|Bir aksiya uchun sof foyda (EPS TTM) Pharvaris|PHVS - So'nggi o'n ikki oy davomida bir aksiya uchun foyda|So'nggi 12 oy davomida bitta aksiya uchun foydaning yillik o'sishi pharvaris.com|PHVS - Joriy yilda foyda o'sishi|Keyingi yil uchun bir aksiya uchun foyda o'sishining konsensus prognozi Pharvaris N.V.
Kompaniyaning umumiy tahlili:PHVS - Pharvaris NV
Ushbu ko'rsatkich bozor kapitalizatsiyasini foyda dinamikasi bilan taqqoslaydi, bu esa aktivning adolatli qiymatini aniqlash va qiymatlar birdan pastga tushganda biznesning qadrsizlanganini identifikatsiya qilish imkonini beradi. Kompaniya qiymatining uning o'sish sur'atiga nisbatini tahlil qilish orqali investor barqaror tijorat daromadlari yo'qligida joriy kapitalizatsiyasi klinik sinovlar bosqichi bilan qo'llab-quvvatlanadigan Pharvaris N.V. (PHVS) kompaniyasining spekulyativ salohiyatini ko'rishi mumkin.
Pharvaris N.V. raqobatchilari
ARGX (argenx N.V.) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori BNTX (BioNTech Group)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Abivax (ABVX)|ADMA - Narxning foydaga va o‘sish sur’atiga nisbati|protagonist-inc.com (PTGX) - Narx-foyda va o‘sish multiplikatori|Immunovant (IMVT) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori Kiniksa Pharmaceuticals, Ltd.|Narx-foyda va o‘sish multiplikatori GRFS|PEG multiplikatori Adaptive Biotechnologies Inc.|Narxning foydaga va o‘sish sur’atiga nisbati Celldex Therapeutics (CLDX)|auriniapharma.com - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|PEG multiplikatori BCRX (BioCryst Pharmaceuticals)|Vera Therapeutics Inc (VERA) - O‘sish sur’atiga tuzatilgan narx-foyda|DNTH - Narxning foydaga va o‘sish sur’atiga nisbati|Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati ABCL|TRML: PEG multiplikatori|precigen.com - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PHAR (Pharming Group) - PEG multiplikatori|PEG multiplikatori Nektar Therapeutics Inc|Narxning foydaga va o‘sish sur’atiga nisbati Upstream Bio Corp (UPB)|ZBIO (Zenas Corp) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Immunome, Inc. - Narx-foyda va o‘sish multiplikatori|gossamerbio.com - Narxning foydaga va o‘sish sur’atiga nisbati|KalVista Pharmaceuticals, Inc. - PEG multiplikatori|SEPN - PEG multiplikatori|Pieris Pharmaceuticals Inc (PVLA) - Narxning foydaga va o‘sish sur’atiga nisbati|Savara Pharma - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|RIGL (Rigel Pharmaceuticals) - PEG multiplikatori|anaptysbio.com (ANAB) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati Astria Therapeutics, Inc. (ATXS)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati enGene Holdings Inc|RAPT Therapeutics, Inc. - Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti JBIO|ACRS - Narxning foydaga va o‘sish sur’atiga nisbati|KYTX (kyvernatx.com) - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|TLSA (Tiziana Life Sciences Ltd) - Narx-foyda va o‘sish multiplikatori|CABA - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narx-foyda va o‘sish multiplikatori VTYX|Narxning foydaga va o‘sish sur’atiga nisbati THTX|Narx-foyda va o‘sish multiplikatori AVTX (Avalo Therapeutics, Inc)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati eledon.com|Narxning foydaga va o‘sish sur’atiga nisbati Agenus Inc. AGEN|CLYM (Climb Bio Inc.) - Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|Zura Bio Limited - PEG multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti ATYR (aTyr Pharmaceuticals)|ADAG (adagene.com) - Narx-foyda va o‘sish multiplikatori|IMA (Ikena Oncology) - Narxning foydaga va o‘sish sur’atiga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati Shattuck Labs Inc|Equillium Bio (EQ) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati Connect Biopharma (CNTB)|IMUX: Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|PEG multiplikatori ATRA (Atara Bio)|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti IFRX|X4 Pharmaceuticals, Inc. - PEG multiplikatori|ACET - PEG multiplikatori|celularity.com (CELU) - Narxning foydaga va o‘sish sur’atiga nisbati|INmune Bio Corporation - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Barinthus Biotherapeutics|Narx-foyda va o‘sish multiplikatori kezarlifesciences.com (KZR)|PEG multiplikatori SABS|PEG multiplikatori Akari Therapeutics PLC (AKTX)|Enlivex Therapeutics Ltd. - Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti QTTB|GeoVax Labs, Inc. - PEG multiplikatori|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati edesabiotech.com EDSA|iBio (IBIO) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori Carisma Therapeutics Inc.|Narxning foydaga va o‘sish sur’atiga nisbati XTL Biopharmaceuticals, Ltd.|Narx-foyda va o‘sish multiplikatori Bolt Bio (BOLT)|Narx-foyda va o‘sish multiplikatori HCWB (HCW Biologics Inc.)|PEG multiplikatori aptevotherapeutics.com (APVO)|Narxning foydaga va o‘sish sur’atiga nisbati AIM ImmunoTech AIM|ADTX: O‘sishni hisobga olgan narx-foyda koeffitsiyenti|GRI Bio Corp - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda XORTX Corp|Vyome Holdings Inc (HIND) - Narxning foydaga va o‘sish sur’atiga nisbati|Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati REVB (revbiosciences.com)|INDP (Indaptus Therapeutics, Inc.) - PEG multiplikatori|SCNI: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori CALI|PEG multiplikatori affimed.com (AFMD)|Narxning foydaga va o‘sish sur’atiga nisbati Allakos ALLK|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti HOOK|IGMS: Narx-foyda va o‘sish multiplikatori|ITOS: Narxning foydaga va o‘sish sur’atiga nisbati|OCEA: PEG multiplikatori|TC BioPharm Ltd (TCBP) - PEG multiplikatori|Narxning foydaga va o‘sish sur’atiga nisbati Third Harmonic Bio
